Companion Spine is the first company in the world with a product portfolio solely focused on Total Disease State Solutions™ (“TDS™”) for degenerative spine diseases. This acquisition creates the world ...

Strategic step to strengthen Companion Spine’s global leadership in posterior dynamic spine stabilization and spine motion preservation. The combined product portfolio will reinforce Companion Spine’s ...

Paradigm Spine has announced it has received FDA approval for its interlaminar technology, according to a news release (pdf). Coflex is a minimally invasive, motion preserving interlaminar ...

Paradigm Spine’s coflex® Interlaminar Stabilization® device is helping ASCs and spine-based practices stand out in a crowded healthcare field. Lumbar spinal stenosis is one of the most common ...

Performance in Q4 was impacted by the early closing of the Companion Spine deal, which removed approximately $2 million of ...

Please provide your email address to receive an email when new articles are posted on . Proprio received FDA 510(k) clearance of its Paradigm spine surgery navigation ...

Paradigm Spine will present a complimentary webinar moderated by Hal Mathews and featuring a Q&A with James Chappuis, MD, from Spine Center Atlanta. Read more and register here. At the Becker's 11th ...

Paradigm Spine LLC, a venture-backed provider of spinal implant technologies, has received up to $75 million in secured debt financing from PDL BioPharma Inc., a publicly traded company that manages ...

The MarketWatch News Department was not involved in the creation of this content. -- Companion Spine is the first company in the world with a product portfolio solely focused on Total Disease State ...

Companion Spine LLC (“Companion Spine” or “the Company”), the French-American specialist in spine implant surgery, announced today that it has completed its previously announced acquisition of the ...